Related Experiment Video

Updated: Feb 24, 2026

Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

9.0K

Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells

Zhenjiang Zhang1, Michael R King1

  • 1Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235 USA.

Cellular and Molecular Bioengineering
|August 15, 2017
PubMed

Insights

Nanomaterials offer a promising solution for capturing rare circulating tumor cells (CTCs), crucial for understanding metastasis and developing new cancer therapies. This approach could revolutionize cancer treatment by enabling direct neutralization of these deadly cells.

Area of Science:

  • Oncology
  • Materials Science
  • Biotechnology

Background:

  • Metastasis, driven by circulating tumor cells (CTCs), causes ~90% of cancer deaths.
  • Detecting and characterizing CTCs is vital for cancer biology and clinical applications.
  • The rarity and heterogeneity of CTCs necessitate highly sensitive and specific isolation techniques.

Purpose of the Study:

  • To review the application of nanomaterials in capturing and therapeutically targeting circulating tumor cells (CTCs).
  • To highlight the significance of nanomaterials in addressing the challenges of CTC detection and isolation.
  • To explore the potential of nanomaterials in next-generation metastatic cancer therapies.

Main Methods:

  • Review of current literature on nanomaterial applications for CTC capture.
  • Analysis of nanomaterial properties relevant to CTC detection and isolation.
  • Discussion of therapeutic strategies involving nanomaterial-mediated CTC targeting.

Main Results:

  • Nanomaterials exhibit unique properties suitable for sensitive and specific CTC capture.
  • Various nanomaterial-based strategies show promise for efficient CTC isolation.
  • Nanomaterials can be engineered for direct therapeutic intervention against CTCs.

Conclusions:

  • Nanomaterials are pivotal in advancing CTC detection, isolation, and characterization.
  • The development of nanomaterial-based therapies holds significant potential for treating metastatic cancer.
  • Future cancer therapies may involve nanomaterial-enabled capture and neutralization of circulating tumor cells.
Keywords:
CancerCirculating tumor cellsMetastasisNanomaterialsNanomedicineNanoparticles

More Related Videos

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K